Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RILMENIDINE vs RISDIPLAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RILMENIDINE vs RISDIPLAM: Safety Overview

Metric RILMENIDINE RISDIPLAM
Total FAERS Reports 899 3,619
Deaths Reported 103 336
Death Rate 11.5% 9.3%
Hospitalizations 536 719
Average Patient Age 73.4 yrs 21.8 yrs
% Female Patients 65.3% 55.2%
FDA Approval Date N/A Aug 7, 2020
Manufacturer N/A Genentech, Inc.
Route N/A ORAL
Marketing Status N/A Prescription